Background and Aims Anthracycline-based chemotherapy (ANTH-BC) has been proposed to increase arterial stiffness, however, the time-dependency of these effects remain unclear. This systematic review and meta-analysis aimed to investigate the time-dependent effect of ANTH-BC on markers of central aortic stiffness, namely aortic distensibility (AD) and pulse-wave-velocity (PWV) in cancer patients. Methods An extensive literature search without language restrictions was performed to identify all studies presenting longitudinal data on the effect of ANTH-BC on either AD and/or central PWV in cancer patients of all ages. An inverse-variance weighted random-effect model was performed with differences from before to after chemotherapy, as ...
Purpose Anthracycline chemotherapy (AC) is associated with acute reductions in cardiopulmonary fitn...
Breast cancer survivors (BCS) who underwent chemotherapy treatment have increased risk of cardiovasc...
[Abstract] INTRODUCTION: Cardiotoxicity represents a major limitation for the use of anthracyclin...
Objective Anthracycline-derived chemotherapy for cancer treatment may cause dose-dependent irreversi...
Purpose: It is well known that anticancer drugs used for treating breast cancer can cause cardiac to...
Survivors of childhood cancer have a significantly higher late morbidity and mortality from cardiova...
BACKGROUND: Anthracyclines and trastuzumab are well recognised to cause cardiac toxicity. Further to...
Abstract Background: Chemotherapy with doxorubicin and cyclophosphamide, although efficient for tre...
Aims. Cardiovascular diseases are the primary cause of premature morbidity and mortality in early br...
Master of ScienceDepartment of KinesiologyCarl AdeBackground – Chemotherapy-induced left ventricular...
Abstract Background Emerging evidence suggests potential arterial damage with the use of anthracycli...
Doctor of PhilosophyDepartment of KinesiologyCarl J. AdeMonitoring changes in left ventricular funct...
ObjectivesThe goal of this study was to determine if low to moderate doses of anthracycline-based ch...
Introduction: The cardiac dysfunction associated with anthracycline-based chemotherapy cancer treatm...
The late-onset cardiotoxic effect of anthracycline is known, however the early detection and prevent...
Purpose Anthracycline chemotherapy (AC) is associated with acute reductions in cardiopulmonary fitn...
Breast cancer survivors (BCS) who underwent chemotherapy treatment have increased risk of cardiovasc...
[Abstract] INTRODUCTION: Cardiotoxicity represents a major limitation for the use of anthracyclin...
Objective Anthracycline-derived chemotherapy for cancer treatment may cause dose-dependent irreversi...
Purpose: It is well known that anticancer drugs used for treating breast cancer can cause cardiac to...
Survivors of childhood cancer have a significantly higher late morbidity and mortality from cardiova...
BACKGROUND: Anthracyclines and trastuzumab are well recognised to cause cardiac toxicity. Further to...
Abstract Background: Chemotherapy with doxorubicin and cyclophosphamide, although efficient for tre...
Aims. Cardiovascular diseases are the primary cause of premature morbidity and mortality in early br...
Master of ScienceDepartment of KinesiologyCarl AdeBackground – Chemotherapy-induced left ventricular...
Abstract Background Emerging evidence suggests potential arterial damage with the use of anthracycli...
Doctor of PhilosophyDepartment of KinesiologyCarl J. AdeMonitoring changes in left ventricular funct...
ObjectivesThe goal of this study was to determine if low to moderate doses of anthracycline-based ch...
Introduction: The cardiac dysfunction associated with anthracycline-based chemotherapy cancer treatm...
The late-onset cardiotoxic effect of anthracycline is known, however the early detection and prevent...
Purpose Anthracycline chemotherapy (AC) is associated with acute reductions in cardiopulmonary fitn...
Breast cancer survivors (BCS) who underwent chemotherapy treatment have increased risk of cardiovasc...
[Abstract] INTRODUCTION: Cardiotoxicity represents a major limitation for the use of anthracyclin...